Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
H.S. freshman Avg
|
|
New words:
abnormally, absolute, ACA, anemia, anniversary, AnorMed, appeal, Asymptomatic, ATPase, Australian, Avalon, AWP, baseline, Bonn, byScientific, Canadian, cardiac, cardiology, case, CFFT, challenging, chemotherapeutic, civil, CMS, colon, communicated, community, comparison, compatible, compliant, constant, contrary, COSO, counteract, criminal, CRP, Darmstadt, Dentsply, deteriorate, discriminate, durable, ECG, ectopy, eighteen, eleven, EMD, Endocrinology, erode, ESPP, eve, exceeded, extra, false, fatigue, feasible, fee, foot, forecasted, foregoing, Framework, gave, Graham, Hartmann, HHS, Holter, Ia, Ib, Icagen, immunodeficiency, imposition, improperly, inflated, inherent, inhibitory, inInternal, inspection, insufficient, interval, intrinsically, isolated, KGaA, Kingdom, Leader, leadership, legislation, legislative, liable, licensee, lucrative, lymphoid, Macalester, magazine, magnitude, matthew, median, Medicaid, medicare, METRO, microbiology, Mitsubishi, mouse, movement, mutated, myelocytic, myeloid, NaV, Nicholson, open, OSI, Oversight, overstated, owe, pancreatic, passage, path, PCI, peginterferon, pertain, phototherapy, point, pre, prescription, prevalent, promulgated, pSivida, QT, ranitidine, rata, redacted, redirection, refine, REFORM, refractory, reinforce, reinforced, remission, repaid, replicon, revert, routine, salary, Shire, silent, simply, slater, spending, stent, stop, successor, summarized, supervision, survival, Tarceva, thein, Thompson, timetable, Tommy, transcriptional, transient, Treadway, unacceptable, unauthorized, unchanged, unclear, undergoing, upregulated, Valeant, ve, ventricular, Victor, virologic, virology, week, Wholesale, withdrawal, withdrawn, xenograft, Zantac
Removed:
Aldrich, Alzheimer, anakinra, apoptotic, applying, appraisal, Asian, assuming, banking, begin, Buchanan, CA, Canada, Celebrex, celecoxib, characterizing, Cilag, coincident, complaint, contest, contesting, death, dedicated, defer, degenerative, delivery, downstream, erosion, etanercept, extensively, extinguishment, extraordinary, fluorescence, gained, genome, genomescreen, Gill, Gold, hired, hybrid, Iain, ibuprofen, impeding, inconvenient, infliximab, interpret, inventor, investing, issuing, Johnson, kind, knockout, Madison, main, mapping, merit, methotrexate, microplate, Motrin, mutual, nearby, neurodegenerative, operation, optimizing, Oregon, painful, Parkinson, partnered, patented, pathway, poorly, presently, programmed, protective, reached, recording, Regional, remeasured, remeasurement, replacement, repressed, retention, retroactively, Richard, run, scanning, Scotland, soft, solved, Southeast, St, subfamily, surgery, surrendered, surrogate, swelling, Switzerland, Tim, TNF, UK, ultra, venture, warrant, Wisconsin, Zug
Filing tables
Filing exhibits
VRTX similar filings
Filing view
External links
QuickLinks -- Click here to rapidly navigate through this document
Exhibit 32.1
SECTION 906 CEO/CFO CERTIFICATION
Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (Subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code) each of the undersigned officers of Vertex Pharmaceuticals Incorporated, a Massachusetts corporation (the "Company"), does hereby certify, to such officer's knowledge, that:
The Annual Report on Form 10-K for the year ended December 31, 2004 (the "Form 10-K") of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and the information contained in the Form 10-K fairly presents, in all material respects, the financial condition and results of operations of the Company.
| Date: March 16, 2005 | ||
/s/ JOSHUA S. BOGER Joshua S. Boger Chairman and Chief Executive Officer | ||
Date: March 16, 2005 | ||
/s/ IAN F. SMITH Ian F. Smith Chief Financial Officer |
SECTION 906 CEO/CFO CERTIFICATION